China Jo-Jo Drugstores, Inc. (CJJD)
USD 1.82
(0.91%)
USD 1.82
(0.91%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 31.1 Million USD | -9.25% |
| 2023 | 34.28 Million USD | -6.13% |
| 2022 | 36.51 Million USD | 24.88% |
| 2021 | 29.24 Million USD | 14.56% |
| 2020 | 25.52 Million USD | 1.67% |
| 2019 | 25.1 Million USD | 24.76% |
| 2018 | 20.12 Million USD | 21.04% |
| 2017 | 16.62 Million USD | -5.05% |
| 2016 | 17.51 Million USD | 40.79% |
| 2015 | 12.43 Million USD | 117.16% |
| 2014 | 5.72 Million USD | -60.86% |
| 2013 | 14.63 Million USD | -46.9% |
| 2012 | 27.56 Million USD | 30.37% |
| 2011 | 21.14 Million USD | 25.12% |
| 2010 | 16.89 Million USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q4 | 7.58 Million USD | 0.0% |
| 2024 Q2 | 7.96 Million USD | 0.0% |
| 2024 FY | 31.1 Million USD | -9.25% |
| 2024 Q3 | 7.58 Million USD | -4.76% |
| 2024 Q1 | 7.96 Million USD | -8.22% |
| 2023 Q2 | 8.46 Million USD | 0.0% |
| 2023 Q1 | 8.46 Million USD | -59.94% |
| 2023 Q3 | 8.67 Million USD | 2.6% |
| 2023 Q4 | 8.67 Million USD | 0.0% |
| 2023 FY | 34.28 Million USD | -6.13% |
| 2022 Q2 | 15.39 Million USD | 100.0% |
| 2022 Q3 | 10.56 Million USD | -31.42% |
| 2022 Q4 | 21.12 Million USD | 100.0% |
| 2022 Q1 | 7.69 Million USD | 24.92% |
| 2022 FY | 36.51 Million USD | 24.88% |
| 2021 FY | 29.24 Million USD | 14.56% |
| 2021 Q1 | 7.98 Million USD | 45.41% |
| 2021 Q3 | 8.08 Million USD | 15.32% |
| 2021 Q4 | 6.16 Million USD | -23.79% |
| 2021 Q2 | 7.01 Million USD | -12.12% |
| 2020 FY | 25.52 Million USD | 1.67% |
| 2020 Q4 | 5.48 Million USD | -24.65% |
| 2020 Q3 | 7.28 Million USD | 8.81% |
| 2020 Q2 | 6.69 Million USD | 10.43% |
| 2020 Q1 | 6.06 Million USD | -7.58% |
| 2019 Q4 | 6.55 Million USD | -8.09% |
| 2019 Q2 | 5.79 Million USD | 3.21% |
| 2019 FY | 25.1 Million USD | 24.76% |
| 2019 Q3 | 7.13 Million USD | 23.09% |
| 2019 Q1 | 5.61 Million USD | 16.57% |
| 2018 Q2 | 5.55 Million USD | 33.03% |
| 2018 FY | 20.12 Million USD | 21.04% |
| 2018 Q1 | 4.17 Million USD | 15.78% |
| 2018 Q3 | 5.57 Million USD | 0.25% |
| 2018 Q4 | 4.81 Million USD | -13.52% |
| 2017 Q3 | 4.18 Million USD | -3.89% |
| 2017 FY | 16.62 Million USD | -5.05% |
| 2017 Q4 | 3.6 Million USD | -13.76% |
| 2017 Q2 | 4.35 Million USD | -2.87% |
| 2017 Q1 | 4.48 Million USD | 3.95% |
| 2016 Q4 | 4.31 Million USD | -11.05% |
| 2016 Q2 | 3.97 Million USD | -9.11% |
| 2016 Q3 | 4.84 Million USD | 21.88% |
| 2016 FY | 17.51 Million USD | 40.79% |
| 2016 Q1 | 4.37 Million USD | 9.94% |
| 2015 Q4 | 3.98 Million USD | 25.08% |
| 2015 Q2 | 2.76 Million USD | 10.14% |
| 2015 Q1 | 2.51 Million USD | 350.77% |
| 2015 FY | 12.43 Million USD | 117.16% |
| 2015 Q3 | 3.18 Million USD | 15.07% |
| 2014 Q2 | 2.94 Million USD | -18.13% |
| 2014 Q3 | 179.08 Thousand USD | -93.93% |
| 2014 Q4 | -1 Million USD | -659.05% |
| 2014 Q1 | 3.6 Million USD | 17.01% |
| 2014 FY | 5.72 Million USD | -60.86% |
| 2013 Q2 | 3.42 Million USD | -33.48% |
| 2013 Q4 | 3.07 Million USD | 2.92% |
| 2013 Q3 | 2.99 Million USD | -12.62% |
| 2013 Q1 | 5.14 Million USD | -32.38% |
| 2013 FY | 14.63 Million USD | -46.9% |
| 2012 Q4 | 7.6 Million USD | 11.45% |
| 2012 FY | 27.56 Million USD | 30.37% |
| 2012 Q3 | 6.82 Million USD | 9.09% |
| 2012 Q2 | 6.25 Million USD | -8.9% |
| 2012 Q1 | 6.86 Million USD | 1.15% |
| 2011 Q1 | 4.61 Million USD | -17.73% |
| 2011 Q4 | 6.79 Million USD | 27.43% |
| 2011 Q3 | 5.32 Million USD | 20.89% |
| 2011 FY | 21.14 Million USD | 25.12% |
| 2011 Q2 | 4.4 Million USD | -4.46% |
| 2010 FY | 16.89 Million USD | 0.0% |
| 2010 Q4 | 5.6 Million USD | 17.66% |
| 2010 Q2 | 3.49 Million USD | 0.0% |
| 2010 Q3 | 4.76 Million USD | 36.24% |
| 2010 Q1 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | -105.67 Thousand USD | 29537.945% |
| BIMI International Medical Inc. | 1.94 Million USD | -1495.351% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 90.55 Million USD | 65.646% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 90.55 Million USD | 65.646% |
| Leafly Holdings, Inc. | 37.45 Million USD | 16.935% |
| Leafly Holdings, Inc. | 37.45 Million USD | 16.935% |
| LifeMD, Inc. | 126.01 Million USD | 75.313% |
| LifeMD, Inc. | 126.01 Million USD | 75.313% |
| TRxADE HEALTH, Inc. | 2.59 Million USD | -1097.285% |
| PetMed Express, Inc. | 78.64 Million USD | 60.446% |
| Walgreens Boots Alliance, Inc. | 26.52 Billion USD | 99.883% |